Alembic Limited has informed the Exchange that Board of Directors at its meeting held on May 19, 2026, recommended Final Dividend of Rs. 2.40 per equity share.
ALEMBICLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.3 pts less than Nifty Microcap 250 and 2.9 pts less than its Residential Commercial Projects peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Alembic Limited's Board recommended a final dividend of Rs. 2.40 per equity share (120% on face value of Rs. 2/-) for FY2026, subject to shareholder approval at the ensuing AGM. This is unchanged from the previous year's dividend of Rs. 2.40 per share. Standalone net profit declined to Rs. 12,454 lakhs from Rs. 14,195 lakhs (down ~12%), while consolidated net profit after accounting for associate share slightly increased to Rs. 31,738 lakhs (vs Rs. 31,068 lakhs). Total standalone revenue grew to Rs. 23,193 lakhs from Rs. 21,436 lakhs. The company operates in Active Pharmaceutical Ingredients and Real Estate segments. Auditors issued an unmodified opinion on both standalone and consolidated financial statements.
The unchanged dividend despite lower standalone earnings signals management confidence, but the declining standalone profit may raise concerns. The stock may see neutral to slightly negative reaction given the profit decline, though the dividend provides some support to investor sentiment.